Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 
Image of a syringe and a bottle of vaccine

What’s the Right Price for Surplus COVID-19 Vaccines? The Answer Is Closer to Zero Than You Might Think.

Many rich countries pre-ordered vast quantities of COVID-19 vaccines when they were still in development, enough to vaccinate their countries many times over.  What is the right ‘price’ to pay for surplus vaccines, as opposed to those newly purchased? And how much of their value should be counted as Official Development Assistance (ODA)? The choice matters for two reasons: firstly, it sets a precedent for the valuation of secondhand goods as development aid, which in turn sets incentives for donors. And secondly, some donors operate an ODA ceiling

Chart showing that spending rose for climate change and global health, while falling for other priority areas

The Shape of Things to Come? FCDO After the Cuts

Since the Foreign, Commonwealth and Development Office (FCDO) began implementing the steep cuts to the UK’s aid budget imposed upon it by the Treasury, much of the immediate reaction has focused on the immense human cost of reducing aid during a global pandemic. What has not been clear, however, is if the cuts are being used to realise a new vision of what UK aid is for. This blog sets out where it looks like the portfolio is going, and the next round of challenges it faces.

A doctor administering a COVID-19 test.

The Future of Development – What Will It Take to Achieve Universal Health?

Among the many disparities and inequities that COVID-19 has shone a light upon, the chasm in health outcomes between rich and poor countries is being particularly sharply highlighted. While Israel, the US, the UK, and a handful of high- and upper-middle income countries are charging forward with their vaccination programmes, many of the poorest are left behind—sometimes to rapidly soaring infection rates, as in India. Universal health—that is, a basic level of health and nutrition achieved globally—seems a distant prospect.

Pages